{
    "title": "Japan's Takeda Pharma raises annual profit forecast on weak yen",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11360435/Japans-Takeda-Pharma-raises-annual-profit-forecast-weak-yen.html",
    "date": "2022-10-27",
    "keywords": [
        "year",
        "profit",
        "yen",
        "takeda",
        "forecast",
        "company",
        "shire",
        "pipeline",
        "value",
        "operating",
        "versus",
        "purchase",
        "dollar",
        "currency",
        "weber",
        "vaccine",
        "tokyo",
        "oct",
        "co",
        "thursday",
        "drugmaker",
        "japan",
        "march",
        "guidance",
        "consensus",
        "survey",
        "scenario",
        "depreciation",
        "downside",
        "executive",
        "christophe",
        "release",
        "plc",
        "footprint",
        "acquisition",
        "debt",
        "latestage",
        "development",
        "focus",
        "oncology",
        "neuroscience",
        "youre",
        "month",
        "opinion",
        "dengue",
        "fever",
        "way",
        "disease",
        "indonesia",
        "country",
        "august",
        "win",
        "drug",
        "growth",
        "franchise",
        "vyvanse",
        "entyvio",
        "patent",
        "protection",
        "absence",
        "gain",
        "sale",
        "core",
        "revision",
        "trading",
        "euro",
        "prevailing",
        "upside",
        "officer",
        "costa",
        "saroukos",
        "drop",
        "benchmark",
        "swift",
        "clarence",
        "fernandez"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}